Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Faces New Foe In Qui Tam Suits; California Insurance Commissioner Intervenes In BMS Case

This article was originally published in The Pink Sheet Daily

Executive Summary

The suit, which has been under seal since 2007, alleges Bristol-Myers Squibb offered kickbacks, including a basketball camp with the Los Angeles Lakers, to encourage physicians to prescribe its drugs.
Advertisement

Related Content

Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ
Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ

Topics

Advertisement
UsernamePublicRestriction

Register

PS071989

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel